IMMUNIC, INC. — Director's Dealing 2017

Jan 17, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-12-31

Reporting Person: Nash Duane (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-23	Common Stock	G	5000	—	Disposed	4324	Direct

Footnotes

F1: Shares gifted by reporting person for no consideration.